{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T14:52:25Z","timestamp":1770907945215,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T00:00:00Z","timestamp":1659657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T00:00:00Z","timestamp":1659657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Congenital myasthenic syndromes (CMSs) are rare genetic diseases due to abnormalities of the neuromuscular junction leading to permanent or transient muscle fatigability and weakness. To date, 32 genes were found to be involved in CMSs with autosomal dominant and\/or recessive inheritance patterns. CMS with acetylcholinesterase deficiency, in particular, was determined to be due to biallelic mutations of <jats:italic>COLQ<\/jats:italic> gene with early-onset clinical signs. Here, we report clinical features and novel molecular findings of <jats:italic>COLQ<\/jats:italic>-related CMS in a Moroccan patient with a review of the literature for this rare form.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>In this study, we report the case of a 28-month-old Moroccan female patient with hypotonia, associated to axial muscle weakness, global motor delay, bilateral ptosis, unilateral partial visual field deficiency with normal ocular motility, and fatigable muscle weakness. Clinical exome sequencing revealed a novel homozygous deletion of exon 13 in <jats:italic>COLQ<\/jats:italic> gene, NM_005677.4(COLQ):c.(814+1_815-1)_(954+1_955-1) del p.(Gly272Aspfs*11). This finding was subsequently confirmed by quantitative real-time PCR (qPCR) in the proband and her parents. In silico analysis of protein-protein interaction network by STRING tool revealed that 12 proteins are highly associated to COLQ with an elevated confidence score. Treatment with Salbutamol resulted in clear benefits and recovery.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This clinical observation illustrates the important place of next-generation sequencing in the precise molecular diagnosis of heterogeneous forms of CMS, the appropriate management and targeted treatment, and genetic counseling of families, with a better characterization of the mutational profile of this rare disease in the Moroccan population.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-022-02822-y","type":"journal-article","created":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T06:08:51Z","timestamp":1659679731000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Novel copy number variation of COLQ gene in a Moroccan patient with congenital myasthenic syndrome: a case report and review of the literature"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6033-2395","authenticated-orcid":false,"given":"Youssef","family":"El Kadiri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilham","family":"Ratbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdelaziz","family":"Sefiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaber","family":"Lyahyai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,5]]},"reference":[{"issue":"1","key":"2822_CR1","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13023-019-1025-5","volume":"14","author":"J Finsterer","year":"2019","unstructured":"Finsterer J. Congenital myasthenic syndromes. Orphanet J Rare Dis. 2019;14(1):57.","journal-title":"Orphanet J Rare Dis."},{"issue":"9","key":"2822_CR2","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1590\/0004-282X20160106","volume":"74","author":"PV Souza","year":"2016","unstructured":"Souza PV, Batistella GN, Lino VC, Pinto WB, Annes M, Oliveira AS. Clinical and genetic basis of congenital myasthenic syndromes. Arq Neuropsiquiatr. 2016;74(9):750\u201360.","journal-title":"Arq Neuropsiquiatr."},{"issue":"Pt 3","key":"2822_CR3","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1093\/brain\/awm325","volume":"131","author":"V Mihaylova","year":"2008","unstructured":"Mihaylova V, Muller JS, Vilchez JJ, Salih MA, Kabiraj MM, D'Amico A, et al. Clinical and molecular genetic findings in COLQ-mutant congenital myasthenic syndromes. Brain. 2008;131(Pt 3):747\u201359.","journal-title":"Brain."},{"issue":"1","key":"2822_CR4","first-page":"28","volume":"36","author":"A Ardissone","year":"2017","unstructured":"Ardissone A, Moroni I, Bernasconi P, Brugnoni R. Congenital myasthenic syndrome: phenotypic variability in patients harbouring p.T159P mutation in CHRNE gene. Acta Myol. 2017;36(1):28\u201332.","journal-title":"Acta Myol."},{"issue":"2","key":"2822_CR5","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s13760-019-01246-9","volume":"121","author":"G Gul Mert","year":"2021","unstructured":"Gul Mert G, Ozcan N, Herguner O, Altunbasak S, Incecik F, Bisgin A, et al. Congenital myasthenic syndrome in Turkey: clinical and genetic features in the long-term follow-up of patients. Acta Neurol Belg. 2021;121(2):529\u201334.","journal-title":"Acta Neurol Belg."},{"issue":"4","key":"2822_CR6","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.nmd.2011.09.002","volume":"22","author":"I Wargon","year":"2012","unstructured":"Wargon I, Richard P, Kuntzer T, Sternberg D, Nafissi S, Gaudon K, et al. Long-term follow-up of patients with congenital myasthenic syndrome caused by COLQ mutations. Neuromuscul Disord. 2012;22(4):318\u201324.","journal-title":"Neuromuscul Disord."},{"issue":"1","key":"2822_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1042\/ETLS20180100","volume":"3","author":"R Thompson","year":"2019","unstructured":"Thompson R, Bonne G, Missier P, Lochmuller H. Targeted therapies for congenital myasthenic syndromes: systematic review and steps towards a treatabolome. Emerg Top Life Sci. 2019;3(1):19\u201337.","journal-title":"Emerg Top Life Sci."},{"issue":"10","key":"2822_CR8","doi-asserted-by":"publisher","first-page":"6999","DOI":"10.1007\/s11033-021-06530-7","volume":"48","author":"R Khaoula","year":"2021","unstructured":"Khaoula R, Cerino M, Da Silva N, Delague V, Nahili H, Kriouile Y, et al. First characterization of congenital myasthenic syndrome type 5 in North Africa. Mol Biol Rep. 2021;48(10):6999\u20137006.","journal-title":"Mol Biol Rep."},{"issue":"16","key":"2822_CR9","doi-asserted-by":"publisher","first-page":"9654","DOI":"10.1073\/pnas.95.16.9654","volume":"95","author":"K Ohno","year":"1998","unstructured":"Ohno K, Brengman J, Tsujino A, Engel AG. Human endplate acetylcholinesterase deficiency caused by mutations in the collagen-like tail subunit (ColQ) of the asymmetric enzyme. Proc Natl Acad Sci U S A. 1998;95(16):9654\u20139.","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"6","key":"2822_CR10","doi-asserted-by":"publisher","first-page":"e117","DOI":"10.1212\/NXG.0000000000000117","volume":"2","author":"W Wang","year":"2016","unstructured":"Wang W, Wu Y, Wang C, Jiao J, Klein CJ. Copy number analysis reveals a novel multiexon deletion of the COLQ gene in congenital myasthenia. Neurol Genet. 2016;2(6):e117.","journal-title":"Neurol Genet."},{"key":"2822_CR11","doi-asserted-by":"crossref","unstructured":"Laforgia N, De Cosmo L, Palumbo O, Ranieri C, Sesta M, Capodiferro D, et al. The First Case of Congenital Myasthenic Syndrome Caused by a Large Homozygous Deletion in the C-Terminal Region of COLQ (Collagen Like Tail Subunit of Asymmetric Acetylcholinesterase) Protein. Genes (Basel). 2020;11(12):1519.","DOI":"10.3390\/genes11121519"},{"issue":"5","key":"2822_CR12","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S1474-4422(15)00010-1","volume":"14","author":"AG Engel","year":"2015","unstructured":"Engel AG, Shen XM, Selcen D, Sine SM. Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment. Lancet Neurol. 2015;14(5):461.","journal-title":"Lancet Neurol."},{"issue":"19","key":"2822_CR13","first-page":"2279","volume":"130","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Dai Y, Han JN, Chen ZH, Ling L, Pu CQ, et al. A Novel AGRN Mutation Leads to Congenital Myasthenic Syndrome Only Affecting Limb-girdle Muscle. Chin Med J (Engl). 2017;130(19):2279\u201382.","journal-title":"Chin Med J (Engl)."},{"issue":"11","key":"2822_CR14","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1007\/s00415-014-7520-7","volume":"261","author":"PM Rodriguez Cruz","year":"2014","unstructured":"Rodriguez Cruz PM, Palace J, Beeson D. Inherited disorders of the neuromuscular junction: an update. J Neurol. 2014;261(11):2234\u201343.","journal-title":"J Neurol."},{"key":"2822_CR15","unstructured":"Abicht A MJS, Lochm\u00fcller H: Congenital Myasthenic Syndromes. 2003 May 9 [Updated 2021 Dec 23]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2021. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1168\/. Accessed 23 May 2022."},{"issue":"9","key":"2822_CR16","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1136\/jnnp.2009.177816","volume":"81","author":"V Mihaylova","year":"2010","unstructured":"Mihaylova V, Scola RH, Gervini B, Lorenzoni PJ, Kay CK, Werneck LC, et al. Molecular characterisation of congenital myasthenic syndromes in Southern Brazil. J Neurol Neurosurg Psychiatry. 2010;81(9):973\u20137.","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"2822_CR17","unstructured":"Filnemus: Protocole National de Diagnostic et de Soins (PNDS). Centre de R\u00e9f\u00e9rence \u00ab Nord Est Ile de France \u00bb H\u00f4pital Armand Trousseau APHP. Mars;\u00a02021. p. 64. Available from:\u00a0https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2021-03\/syndromes_myastheniques_congenitaux_-_pnds.pdf. Accessed 23 May 2022."},{"issue":"6","key":"2822_CR18","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1002\/mus.26676","volume":"60","author":"S Nicolau","year":"2019","unstructured":"Nicolau S, Kao JC, Liewluck T. Trouble at the junction: When myopathy and myasthenia overlap. Muscle Nerve. 2019;60(6):648\u201357.","journal-title":"Muscle Nerve."},{"issue":"12","key":"2822_CR19","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.nmd.2014.07.005","volume":"24","author":"PM Rodriguez Cruz","year":"2014","unstructured":"Rodriguez Cruz PM, Sewry C, Beeson D, Jayawant S, Squier W, McWilliam R, et al. Congenital myopathies with secondary neuromuscular transmission defects; a case report and review of the literature. Neuromuscul Disord. 2014;24(12):1103\u201310.","journal-title":"Neuromuscul Disord."},{"issue":"12","key":"2822_CR20","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/j.nmd.2020.11.009","volume":"30","author":"L Benarroch","year":"2020","unstructured":"Benarroch L, Bonne G, Rivier F, Hamroun D. The 2021 version of the gene table of neuromuscular disorders (nuclear genome). Neuromuscul Disord. 2020;30(12):1008\u201348.","journal-title":"Neuromuscul Disord."},{"issue":"1","key":"2822_CR21","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12883-016-0716-y","volume":"16","author":"T Chang","year":"2016","unstructured":"Chang T, Cossins J, Beeson D. A rare c.183_187dupCTCAC mutation of the acetylcholine receptor CHRNE gene in a South Asian female with congenital myasthenic syndrome: a case report. BMC Neurol. 2016;16(1):195.","journal-title":"BMC Neurol."},{"key":"2822_CR22","doi-asserted-by":"crossref","unstructured":"Rodriguez Cruz PM, Palace J, Beeson D. The Neuromuscular Junction and Wide Heterogeneity of Congenital Myasthenic Syndromes. Int J Mol Sci. 2018;19(6):1677.","DOI":"10.3390\/ijms19061677"},{"key":"2822_CR23","doi-asserted-by":"publisher","first-page":"560860","DOI":"10.3389\/fnhum.2020.560860","volume":"14","author":"A Della Marina","year":"2020","unstructured":"Della Marina A, Wibbeler E, Abicht A, Kolbel H, Lochmuller H, Roos A, et al. Long Term Follow-Up on Pediatric Cases With Congenital Myasthenic Syndromes-A Retrospective Single Centre Cohort Study. Front Hum Neurosci. 2020;14:560860.","journal-title":"Front Hum Neurosci."},{"key":"2822_CR24","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jocn.2020.01.080","volume":"75","author":"PJ Lorenzoni","year":"2020","unstructured":"Lorenzoni PJ, Kay CSK, Arndt RC, Hrysay NMC, Ducci RD, Fustes OHJ, et al. Congenital myasthenic syndrome due to DOK7 mutation in a cohort of patients with 'unexplained' limb-girdle muscular weakness. J Clin Neurosci. 2020;75:195\u20138.","journal-title":"J Clin Neurosci."},{"issue":"1","key":"2822_CR25","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/nyas.13595","volume":"1413","author":"C Legay","year":"2018","unstructured":"Legay C. Congenital myasthenic syndromes with acetylcholinesterase deficiency, the pathophysiological mechanisms. Ann N Y Acad Sci. 2018;1413(1):104\u201310.","journal-title":"Ann N Y Acad Sci."},{"key":"2822_CR26","doi-asserted-by":"publisher","first-page":"568171","DOI":"10.3389\/fnmol.2020.568171","volume":"13","author":"J Karmouch","year":"2020","unstructured":"Karmouch J, Delers P, Semprez F, Soyed N, Areias J, Belanger G, et al. AChR beta-Subunit mRNAs Are Stabilized by HuR in a Mouse Model of Congenital Myasthenic Syndrome With Acetylcholinesterase Deficiency. Front Mol Neurosci. 2020;13:568171.","journal-title":"Front Mol Neurosci."},{"issue":"12","key":"2822_CR27","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1212\/WNL.0000000000001396","volume":"84","author":"R Al-Shahoumi","year":"2015","unstructured":"Al-Shahoumi R, Brady LI, Schwartzentruber J, Tarnopolsky MA. Two cases of congenital myasthenic syndrome with vocal cord paralysis. Neurology. 2015;84(12):1281\u20132.","journal-title":"Neurology."},{"issue":"1","key":"2822_CR28","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.pediatrneurol.2014.03.012","volume":"51","author":"HN Matlik","year":"2014","unstructured":"Matlik HN, Milhem RM, Saadeldin IY, Al-Jaibeji HS, Al-Gazali L, Ali BR. Clinical and molecular analysis of a novel COLQ missense mutation causing congenital myasthenic syndrome in a Syrian family. Pediatr Neurol. 2014;51(1):165\u20139.","journal-title":"Pediatr Neurol."},{"key":"2822_CR29","doi-asserted-by":"publisher","first-page":"679342","DOI":"10.3389\/fped.2021.679342","volume":"9","author":"X Luo","year":"2021","unstructured":"Luo X, Wang C, Lin L, Yuan F, Wang S, Wang Y, et al. Mechanisms of Congenital Myasthenia Caused by Three Mutations in the COLQ Gene. Front Pediatr. 2021;9:679342.","journal-title":"Front Pediatr."},{"issue":"1","key":"2822_CR30","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s41436-018-0033-5","volume":"21","author":"R Truty","year":"2019","unstructured":"Truty R, Paul J, Kennemer M, Lincoln SE, Olivares E, Nussbaum RL, et al. Prevalence and properties of intragenic copy-number variation in Mendelian disease genes. Genet Med. 2019;21(1):114\u201323.","journal-title":"Genet Med."},{"issue":"5","key":"2822_CR31","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/nrg2958","volume":"12","author":"C Alkan","year":"2011","unstructured":"Alkan C, Coe BP, Eichler EE. Genome structural variation discovery and genotyping. Nat Rev Genet. 2011;12(5):363\u201376.","journal-title":"Nat Rev Genet."},{"issue":"3","key":"2822_CR32","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.coph.2009.04.004","volume":"9","author":"J Massoulie","year":"2009","unstructured":"Massoulie J, Millard CB. Cholinesterases and the basal lamina at vertebrate neuromuscular junctions. Curr Opin Pharmacol. 2009;9(3):316\u201325.","journal-title":"Curr Opin Pharmacol."},{"key":"2822_CR33","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1196\/annals.1254.016","volume":"998","author":"AG Engel","year":"2003","unstructured":"Engel AG, Ohno K, Shen XM, Sine SM. Congenital myasthenic syndromes: multiple molecular targets at the neuromuscular junction. Ann N Y Acad Sci. 2003;998:138\u201360.","journal-title":"Ann N Y Acad Sci."},{"issue":"6","key":"2822_CR34","doi-asserted-by":"publisher","first-page":"194416","DOI":"10.1016\/j.bbagrm.2019.194416","volume":"1863","author":"F Conte","year":"2020","unstructured":"Conte F, Fiscon G, Licursi V, Bizzarri D, D'Anto T, Farina L, et al. A paradigm shift in medicine: A comprehensive review of network-based approaches. Biochim Biophys Acta Gene Regul Mech. 2020;1863(6):194416.","journal-title":"Biochim Biophys Acta Gene Regul Mech."},{"issue":"4","key":"2822_CR35","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1093\/bib\/bbz064","volume":"21","author":"D Guala","year":"2020","unstructured":"Guala D, Ogris C, Muller N, Sonnhammer ELL. Genome-wide functional association networks: background, data & state-of-the-art resources. Brief Bioinform. 2020;21(4):1224\u201337.","journal-title":"Brief Bioinform."}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-022-02822-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-022-02822-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-022-02822-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T06:10:34Z","timestamp":1659679834000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-022-02822-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,5]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2822"],"URL":"https:\/\/doi.org\/10.1186\/s12883-022-02822-y","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,5]]},"assertion":[{"value":"14 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All genetic testing in this study were performed after consent from the parents of the proband in accordance with the tenets of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written consent has been obtained from the parents\/legal guardians for publication of clinical details, biological and molecular data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"292"}}